Results

Protagonist Therapeutics Inc.

03/22/2021 | Press release | Archived content

Protagonist Announces Plans to Initiate a Global Phase 3 Study for Rusfertide in Polycythemia Vera Following Interactions with the U.S. Food & Drug Administration and the[...]